Brinzolamide - Latest Advances

Managing Persistent Pupillary Membranes With Surgery or Medication: A Report of Three Cases.

Journal: Cureus

Published: June 24, 2025

Thermoresponsive Hydrogels with Tunable Viscoelasticity for Extended Ocular Drug Delivery.

Journal: Biomacromolecules

Published: May 29, 2025

Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma.

Journal: Veterinary ophthalmology

Published: May 19, 2025

Drugs for open-angle glaucoma.

Journal: The Medical letter on drugs and therapeutics

Published: April 22, 2025

Comparison of the Effects of Timolol, Brinzolamide, Brimonidine and Netarsudil in a Rabbit Model of Water Loading-Induced Ocular Hypertension.

Journal: Current eye research

Published: March 06, 2025

Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment.

Journal: Materials today. Bio

Published: February 23, 2025

Sustained intraocular pressure-lowering effect and biocompatibility of a single subconjunctival administration of hydrogel-encapsulated nano-brinzolamide.

Journal: Journal of materials science. Materials in medicine

Published: February 06, 2025

Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift.

Journal: BMJ case reports

Published: January 27, 2025

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Journal: International journal of pharmaceutics

Published: January 13, 2025

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Journal: International journal of pharmaceutics

Published: January 13, 2025

Review: Clinical findings and genetic characterization of children affected with X-linked retinoschisis in the Spanish population.

Journal: European journal of ophthalmology

Published: December 09, 2024

Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study.

Journal: Cureus

Published: September 21, 2024

Filters

Managing Persistent Pupillary Membranes With Surgery or Medication: A Report of Three Cases.

Managing Persistent Pupillary Membranes With Surgery or Medication: A Report of Three Cases.

Thermoresponsive Hydrogels with Tunable Viscoelasticity for Extended Ocular Drug Delivery.

Thermoresponsive Hydrogels with Tunable Viscoelasticity for Extended Ocular Drug Delivery.

Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma.

Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma.

Drugs for open-angle glaucoma.

Drugs for open-angle glaucoma.

Comparison of the Effects of Timolol, Brinzolamide, Brimonidine and Netarsudil in a Rabbit Model of Water Loading-Induced Ocular Hypertension.

Comparison of the Effects of Timolol, Brinzolamide, Brimonidine and Netarsudil in a Rabbit Model of Water Loading-Induced Ocular Hypertension.

Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment.

Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment.

Sustained intraocular pressure-lowering effect and biocompatibility of a single subconjunctival administration of hydrogel-encapsulated nano-brinzolamide.

Sustained intraocular pressure-lowering effect and biocompatibility of a single subconjunctival administration of hydrogel-encapsulated nano-brinzolamide.

Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift.

Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift.

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

Review: Clinical findings and genetic characterization of children affected with X-linked retinoschisis in the Spanish population.

Review: Clinical findings and genetic characterization of children affected with X-linked retinoschisis in the Spanish population.

Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study.

Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study.